Avedro Overview

  • Year Founded
  • 2002

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 122

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $438M

Avedro General Information

Description

Avedro Inc is a commercial-stage ophthalmic medical technology company focused on treating corneal ectatic disorders and improving vision to reduce dependency on eyeglasses or contact lenses. Its Avedro Corneal Remodeling Platform is designed to strengthen, stabilize and reshape the cornea utilizing corneal cross-linking in minimally invasive and non-invasive outpatient procedures to treat corneal ectatic disorders and correct refractive conditions. The company geographically operates through United States, Asia, Europe, Americas (outside the United States), Middle East and Other locations.

Contact Information

Website
www.avedro.com
Formerly Known As
ThermalVision
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Acquirer
Glaukos
Corporate Office
  • 201 Jones Road
  • Waltham, MA 02451
  • United States
+1 (781) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Avedro Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Merger/Acquisition 21-Nov-2019 $438M 00000 00000 Completed Profitable
10. IPO 14-Feb-2019 0000 00000 00000 Completed Profitable
9. Later Stage VC (Series CC) 26-Apr-2018 0000 00000 00000 Completed Profitable
8. Later Stage VC (Series BB) 27-Apr-2017 0000 00000 Completed Profitable
7. Later Stage VC (Series AA) 13-Nov-2015 000.00 00000 000.00 Completed Profitable
6. Later Stage VC (Series D) 05-Nov-2014 000.00 00000 000.00 Completed Profitable
5. Later Stage VC (Series D) 05-Mar-2013 0000 00000 0000 Completed Profitable
4. Later Stage VC (Series C) 17-Feb-2012 000.00 000.00 000.00 Completed Profitable
3. Later Stage VC (Series B) 08-May-2009 $10M $19.6M 000.00 Completed Profitable
2. Later Stage VC (Series A1) 29-Jan-2008 $8M $9.6M 000.00 Completed Profitable
To view Avedro’s complete valuation and funding history, request access »

Avedro Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate ($) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series CC 0,000,000 00.00 00.00 00.00 00 00.00 00.000
Series BB 0,000,000 00.00 00.00 00.00 00 00.00 0.000
Series AA 32,650,000 $0.08 $1 $1 1x $1 48.95%
To view Avedro’s complete cap table history, request access »

Avedro Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Avedro Inc is a commercial-stage ophthalmic medical technology company focused on treating corneal ectatic disorders and
Pharmaceuticals
Waltham, MA
122 As of 2018
00000
00000 0000-00-00
000000&0 00000

000000

is nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehender
000000000000000
Farmington Hills, MI
00 As of 0000
00000
00000000 00000

000000

aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi
0000000000000
Alpharetta, GA
00 As of 0000
00000
00000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Avedro Competitors (4)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Ocuphire Pharma Formerly VC-backed Farmington Hills, MI 00 00000 00000000 00000
Clearside Biomedical Formerly VC-backed Alpharetta, GA 00 00000 00000000 00000
Bausch Health Brasil Corporation Sao Paulo, Brazil 000
VISUfarma Private Equity-Backed Amsterdam, Netherlands 000 00000000000
To view Avedro’s complete competitors history, request access »

Avedro Patents

  • 294

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 139

    Granted

  • 90

    Pending

  • 000

    Expiring in next 12 mo

Avedro Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20220284575-A1 Systems and methods for generating patient-specific corneal cross-linking treatment patterns Pending 08-Mar-2021 0000000000
CA-3213111-A1 Systems and methods for generating patient-specific corneal cross-linking treatment patterns Pending 08-Mar-2021 0000000000
AU-2022232309-A1 Systems and methods for generating patient-specific corneal cross-linking treatment patterns Pending 08-Mar-2021 0000000000
EP-4304539-A1 Systems and methods for generating patient-specific corneal cross-linking treatment patterns Pending 08-Mar-2021 0000000000
JP-2024511317-A Systems and methods for generating patient-specific corneal crosslinking treatment patterns Pending 08-Mar-2021 A61F9/0079
To view Avedro’s complete patent history, request access »

Avedro Board Members (21)

Name Representing Role Since
Hongbo Lu Ph.D Lilly Asia Ventures Board Member 000 0000
You’re viewing 1 of 21 board members. Get the full list »

Avedro Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Avedro Former Investors (17)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Abingworth Venture Capital Minority 000 0000 000000 0
Aperture Venture Partners Venture Capital Minority 000 0000 000000 0
Borealis Ventures Venture Capital Minority 000 0000 000000 0
De Novo Ventures Venture Capital Minority 000 0000 000000 0
Echelon Ventures Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 17 investors. Get the full list »

Avedro Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
IROC Innocross 03-Sep-2014 0000000000 Diagnostic Equipment
To view Avedro’s complete acquisitions history, request access »

Ready to get started?

Request a free trial

Avedro FAQs

  • When was Avedro founded?

    Avedro was founded in 2002.

  • Who is the founder of Avedro?

    David Muller Ph.D is the founder of Avedro.

  • Where is Avedro headquartered?

    Avedro is headquartered in Waltham, MA.

  • What is the size of Avedro?

    Avedro has 122 total employees.

  • What industry is Avedro in?

    Avedro’s primary industry is Pharmaceuticals.

  • Is Avedro a private or public company?

    Avedro is a Private company.

  • What is the current valuation of Avedro?

    The current valuation of Avedro is 00000.

  • What is Avedro’s current revenue?

    The current revenue for Avedro is 00000.

  • How much funding has Avedro raised over time?

    Avedro has raised $297M.

  • Who are Avedro’s investors?

    Abingworth, Aperture Venture Partners, Borealis Ventures, De Novo Ventures, and Echelon Ventures are 5 of 17 investors who have invested in Avedro.

  • Who are Avedro’s competitors?

    Ocuphire Pharma, Clearside Biomedical, Bausch Health Brasil, and VISUfarma are competitors of Avedro.

  • When was Avedro acquired?

    Avedro was acquired on 21-Nov-2019.

  • Who acquired Avedro?

    Avedro was acquired by Glaukos.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »